Axcynsis Therapeutics
PrivateLast Round
VC Round
Oct 1, 2024
Total Funding Raised
$15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Axcynsis Therapeutics is a biotechnology company that develops antibody-drug conjugate (ADC) therapies designed for treating cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axcynsis Therapeutics Comparables
Compare Axcynsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DotBio | 82% | |
| Albatroz Therapeutics | 79% | |
| Adcytherix | 78% |
Axcynsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2024 | ||||
| Seed | May 4, 2022 |
Axcynsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trinity Innovation Fund | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 188% MoM, reaching 916.
- Apr 21, 2025
Developing new Antibody Drug Conjugate (ADC) therapies.
Axcynsis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axcynsis Therapeutics's valuation, stock price, and market status.
Is Axcynsis Therapeutics a public or private company?
Axcynsis Therapeutics is a private company.
What is the current stock price of Axcynsis Therapeutics?
Axcynsis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Axcynsis Therapeutics worth (valuation)?
Valuation information for Axcynsis Therapeutics is not publicly available.
Can I buy Axcynsis Therapeutics stock?
Axcynsis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axcynsis Therapeutics's last funding round?
Axcynsis Therapeutics's most recent funding round was VC Round on October 1, 2024.
Who are the main investors in Axcynsis Therapeutics?
Key investors in Axcynsis Therapeutics include Trinity Innovation Fund.
Will Axcynsis Therapeutics IPO soon?
No public IPO plans have been announced for Axcynsis Therapeutics.
How can I track Axcynsis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axcynsis Therapeutics's secondary market activity and sign up for updates.